Skip to main content

Care

By Jessica Hagen | 11:15 am | January 09, 2026
The digital pharmacy will sell the newly FDA-approved weight-loss pill nationwide, allowing patients to pay through their insurance or in cash.
By Jessica Hagen | 12:54 pm | January 07, 2026
Ceribell received breakthrough device designation for its LVO stroke detection monitor, and Naox Technologies secured 510(k) clearance for its in-ear EEG device.
By HIMSS TV | 10:11 am | January 07, 2026
Sutter Health's Dr. Richard Milani and Epic's Trevor Berceau talk about Sutter's chronic care program, which integrates readings from remote monitoring devices into the EHR to give doctors continuous insight into patients' conditions.
By Nathan Eddy | 12:33 pm | January 06, 2026
A Mesothelioma Center report finds that more than half of Americans use ChatGPT for medical symptoms, widening a gap between patient reliance on AI and clinician concerns.
By Jessica Hagen | 10:10 am | January 06, 2026
The collaboration will allow patients considering the oral GLP-1 therapy to access metabolic care through knownwell’s hybrid model.
By HIMSS TV | 09:38 am | January 05, 2026
While HIMSS Media editors anticipate that AI will be used in every layer of healthcare's tech stack in 2026, they stress that governance and human oversight are essential to ensure AI works safely at scale.
By Susan Morse | 04:05 pm | January 02, 2026
Pharma faces regulations and stringent rules for transparency, but the payoff is drugs that can get to market faster and possibly at less expense.
By HIMSS TV | 10:06 am | January 02, 2026
Sallie Gustafson, Murj's director of medical affairs, says Emory used smart remote monitoring technology that integrates with EHR systems to increase billable remote cardiac services by 52% despite minimal patient growth.
By Andrea Fox | 04:34 pm | December 31, 2025
All 50 states were awarded funding to launch their proposals to achieve sustainable rural healthcare over a 10-year timeframe. See how much each stated received.
By Jessica Hagen | 11:48 am | December 31, 2025
The extension allows providers to continue remotely prescribing Schedule II–V controlled substances under specific conditions to prevent a disruptive "telemedicine cliff."